NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-257-2010-0-IL-21 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IL DIV 259648 Issued
NCATS E-257-2010-0-CA-04 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CA National Stage 2820362 Issued
NCATS E-257-2010-0-IN-11 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IN National Stage 5102/DELNP/2013 Issued
NCATS E-257-2010-0-KR-12 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators KR National Stage 10-2013-7017520 Issued
NCATS E-257-2010-0-IL-06 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IL National Stage 226767 Issued
NCATS E-257-2010-0-HU-32 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators HU EP 11810714.3 Issued
NCATS E-257-2010-0-IS-34 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IS EP 11810714.3 Issued
NCATS E-257-2010-0-IT-35 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IT EP 11810714.3 Issued
NCATS E-257-2010-0-GR-31 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators GR EP 11810714.3 Issued
NCATS E-257-2010-0-IE-33 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IE EP 11810714.3 Issued
NCATS E-257-2010-0-PL-39 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators PL EP 11810714.3 Issued
NCATS E-257-2010-0-PT-40 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators PT EP 11810714.3 Issued
NCATS E-257-2010-0-ES-28 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators ES EP 11810714.3 Issued
NCATS E-257-2010-0-SK-42 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SK EP 11810714.3 Issued
NCATS E-257-2010-0-NO-38 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators NO EP 11810714.3 Issued
NCATS E-257-2010-0-SI-44 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SI EP 11810714.3 Issued
NCATS E-257-2010-0-SE-41 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SE EP 11810714.3 Issued
NCATS E-257-2010-0-BE-23 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators BE EP 11810714.3 Issued
NCATS E-257-2010-0-AT-22 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators AT EP 11810714.3 Issued
NCATS E-257-2010-0-EP-05 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators EP National Stage 11810714.3 Issued
NCATS E-257-2010-0-NL-37 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators NL EP 11810714.3 Issued
NCATS E-257-2010-0-LU-36 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LU EP 11810714.3 Issued
NCATS E-257-2010-0-CH-24 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CH EP 11810714.3 Issued
NCATS E-257-2010-0-GB-30 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators GB EP 11810714.3 Issued
NCATS E-257-2010-0-TR-43 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators TR EP 11810714.3 Issued
NCATS E-257-2010-0-DK-26 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators DK EP 11810714.3 Issued
NCATS E-257-2010-0-EE-27 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators EE EP 11810714.3 Issued
NCATS E-257-2010-0-DE-25 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators DE EP 11810714.3 Issued
NCATS E-257-2010-0-FR-29 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators FR EP 11810714.3 Issued
NCATS E-257-2010-0-MX-13 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators MX National Stage MX/a/2013/006462 Issued
NCATS E-257-2010-0-JP-07 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators JP National Stage 2013-543335 Issued
NCATS E-257-2010-0-CN-10 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CN National Stage 201180066859.7 Issued
NCATS E-257-2010-0-RU-14 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators RU National Stage 2013126094 Issued
NCATS E-257-2010-0-AU-03 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators AU National Stage 2011338377 Issued
NIDCR E-300-2008-0-US-03 Identification Of DSG-3 As A Biomarker For The Detection Of Metastasis In Lymph Nodes US National Stage 13/376,984 9151762 Issued PDF
NCATS E-257-2010-0-ZA-15 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators ZA National Stage 2013/04215 Issued
NIAID E-051-2012-0-US-01 Neutralizing Antibodies To HIV-1 And Their Use US 61/568,520 Abandoned
NHGRI E-044-2013-0-US-01 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) US 61/568,590 Abandoned
NCATS E-257-2010-0-PCT-02 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators PCT PCT PCT/US11/063928 Expired
NCI E-069-2010-0-PCT-02 MODULATING IMMUNE CELL ACTIVITY USING CYTOKINE-INDUCED SRC HOMOLOGY 2 AND/OR HIGH TEMPERATURE REQUIREMENT A-1 PCT PCT PCT/US2011/63375 Abandoned
NCI E-294-2010-0-PCT-02 PHARMACEUTICAL COMPOSITION COMPRISING NANOG SHRNA, AND METHOD OF USING NANOG SHRNA TO TREAT CANCER PCT PCT PCT/US11/063451 Expired
NIAID E-041-2012-0-US-01 Development Of Anti-Idiotypic Antibodies Against HIV Neutralizing Monoclonal Antibodies US 61/567,482 Abandoned
E-237-2014-0-US-01 Cerium Oxide Nanoparticles And Associated Methods For Promoting Wound Healing US 61/567,184 Abandoned
NINDS E-133-2006-1-US-12 Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses US DIV 13/310,965 Abandoned
NINDS E-043-2012-0-US-01 SuBLIME: Automatic Brain Lesion Incidence And Detection Using Multimodality Longitudinal Magnetic Resonance Imaging US 61/630,101 Abandoned
NIA E-045-2012-0-US-01 THIO COMPOUNDS US ORD 13/310,242 8927725 Issued PDF
NIAID E-051-2002-0-US-07 METHODS FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND INFLAMMATION US DIV 13/310,264 8716301 Expired PDF
NIAID E-123-2007-0-US-05 Monoclonal Antibodies That Neutralize Anthrax Toxin US DIV 13/310,463 8574853 Abandoned PDF
NIAID E-575-2013-0-US-01 VACCINE FOR FALCIPARUM MALARIA US 61/566,365 Abandoned
NIAID E-031-2012-0-US-01 Chimeric JEV/DEN4 Vaccine Candidates For Control Of Japanese Encephalitis US 61/566,560 Abandoned